- Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
-
Jin Su Kim, Su Cheol Park
-
J Liver Cancer. 2016;16(2):82-85. Published online September 30, 2016
-
DOI: https://doi.org/10.17998/jlc.16.2.82
-
-
 Abstract
 PDF
- Transarterial chemoembolization (TACE) has been widely performed as a treatment for
unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC
is increasing due to improvement of survival. Sorafenib has been generally accepted as a
standard treatment in advanced HCC. However, many HCC patients with EHM are treated with
TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause
of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for
the patients with HCC and EHM will be discussed.
|
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Follow JLC on Twitter